Neoadjuvant therapy with ipilimumab and nivolumab for stage III malignant melanoma - a case report

被引：0

作者：

Hansen, I. ^{[1
]}

Heidrich, I. ^{[1
]}

Belz, S. ^{[1
]}

Noebel, C. ^{[1
]}

Geidel, G. ^{[1
]}

Hildebrandt, L. ^{[1
]}

Schneider, S. W. ^{[1
]}

Gebhardt, C. ^{[1
]}

机构：

[1] Univ Klinikum Hamburg Eppendorf, Klin Dermatol & Venerol, Hamburg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

eP096

引用

页码：87 / 88

页数：2

共 50 条

[1] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
Blank, Christian U.
Lucas, Minke W.
Scolyer, Richard A.
van de Wiel, Bart A.
Menzies, Alexander M.
Lopez-Yurda, Marta
Hoeijmakers, Lotte L.
Saw, Robyn P. M.
Lijnsvelt, Judith M.
Maher, Nigel G.
Pulleman, Saskia M.
Gonzalez, Maria
Torres Acosta, Alejandro
van Houdt, Winan J.
Lo, Serigne N.
Kuijpers, Anke M. J.
Spillane, Andrew
Klop, W. Martin C.
Pennington, Thomas E.
Zuur, Charlotte L.
Shannon, Kerwin F.
Seinstra, Beatrijs A.
Rawson, Robert V.
Haanen, John B. A. G.
Ch'ng, Sydney
Naipal, Kishan A. T.
Stretch, Jonathan
van Thienen, Johannes V.
Rtshiladze, Michael A.
Wilgenhof, Sofie
Kapoor, Rony
Meerveld-Eggink, Aafke
Grijpink-Ongering, Lindsay G.
van Akkooi, Alexander C. J.
Reijers, Irene L. M.
Gyorki, David E.
Gruenhagen, Dirk J.
Speetjens, Frank M.
Vliek, Sonja B.
Placzke, Joanna
Spain, Lavinia
Stassen, Robert C.
Amini-Adle, Mona
Lebbe, Celeste
Faries, Mark B.
Robert, Caroline
Ascierto, Paolo A.
van Rijn, Rozemarijn
van den Berkmortel, Franchette W. P. J.
Piersma, Djura
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (18): : 1696 - 1708
[2] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
Blank, Christian U.
Lucas, Minke W.
Scolyer, Richard A.
van de Wiel, Bart A.
Menzies, Alexander M.
Lopez-Yurda, Marta
Hoeijmakers, Lotte L.
Saw, Robyn P. M.
Lijnsvelt, Judith M.
Maher, Nigel G.
Pulleman, Saskia M.
Gonzalez, Maria
Acosta, Alejandro Torres
van Houdt, Winan J.
Lo, Serigne N.
Kuijpers, Anke M. J.
Spillane, Andrew
Klop, W. Martin C.
Pennington, Thomas E.
Zuur, Charlotte L.
Shannon, Kerwin F.
Seinstra, Beatrijs A.
Rawson, Robert V.
Haanen, John B. A. G.
Ch'ng, Sydney
Naipal, Kishan A. T.
Stretch, Jonathan
van Thienen, Johannes V.
Rtshiladze, Michael A.
Wilgenhof, Sofie
Kapoor, Rony
Meerveld-Eggink, Aafke
Grijpink-Ongering, Lindsay G.
van Akkooi, Alexander C. J.
Reijers, Irene L. M.
Gyorki, David E.
Gruenhagen, Dirk J.
Speetjens, Frank M.
Vliek, Sonja B.
Placzke, Joanna
Spain, Lavinia
Stassen, Robert C.
Amini-Adle, Mona
Lebbe, Celeste
Faries, Mark B.
Robert, Caroline
Ascierto, Paolo A.
van Rijn, Rozemarijn
van den Berkmortel, Franchette W. P. J.
Piersma, Djura
NEW ENGLAND JOURNAL OF MEDICINE, 2024,
[3] Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable stage III melanoma
Lowe, M.
Yushak, M. L.
Olson, B.
Mokhtari, A.
Harutyunyan, A.
Delman, K.
Parker, D.
Evans, E.
Fisher, T.
Lesinski, G.
Kudchadkar, R.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S906 - S906
[4] Neoadjuvant Pepinemab in Combination with Nivolumab and/ or Ipilimumab in Resectable Stage III Melanoma
Lowe, Michael C.
Olson, Brian
Yushak, Melinda
Mallow, Crystal
Reilly, Christine
Hammons, Jacklyn
Burns, Brian
Mokhtari, Ali
Parker, Doug
Fisher, Terry
Evans, Elizabeth
Paulos, Chrystal
Delman, Keith
Lesinski, Gregory
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S5 - S5
[5] Neoadjuvant Nivolumab and Ipilimumab for Resectable Stage III Melanoma: The New Standard of Care?
Miura, John T.
Karakousis, Giorgos C.
ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (03) : 1394 - 1396
[6] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Blank, Christian U.
Rozeman, Elisa A.
Fanchi, Lorenzo F.
Sikorska, Karolina
van de Wiel, Bart
Kvistborg, Pia
Krijgsman, Oscar
van den Braber, Marlous
Philips, Daisy
Broeks, Annegien
van Thienen, Johannes, V
Mallo, Henk A.
Adriaansz, Sandra
ter Meulens, Sylvia
Pronk, Loes M.
Grijpink-Ongering, Lindsay G.
Bruining, Annemarie
Gittelman, Rachel M.
Warren, Sarah
van Tinteren, Harm
Peeper, Daniel S.
Haanen, John B. A. G.
van Akkooi, Alexander C. J.
Schumacher, Ton N.
NATURE MEDICINE, 2018, 24 (11) : 1655 - +
[7] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Christian U. Blank
Elisa A. Rozeman
Lorenzo F. Fanchi
Karolina Sikorska
Bart van de Wiel
Pia Kvistborg
Oscar Krijgsman
Marlous van den Braber
Daisy Philips
Annegien Broeks
Johannes V. van Thienen
Henk A. Mallo
Sandra Adriaansz
Sylvia ter Meulen
Loes M. Pronk
Lindsay G. Grijpink-Ongering
Annemarie Bruining
Rachel M. Gittelman
Sarah Warren
Harm van Tinteren
Daniel S. Peeper
John B. A. G. Haanen
Alexander C. J. van Akkooi
Ton N. Schumacher
Nature Medicine, 2018, 24 : 1655 - 1661
[8] Original Research Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Versluis, Judith M.
Reijers, Irene L. M.
Rozeman, Elisa A.
Menzies, Alexander M.
van Akkooi, Alexander C. J.
Wouters, Michel W.
Ch'ng, Sydney
Saw, Robyn P. M.
Scolyer, Richard A.
van de Wiel, Bart A.
Schilling, Bastian
Long, Georgina, V
Blank, Christian U.
EUROPEAN JOURNAL OF CANCER, 2021, 148 : 51 - 57
[9] Experience with nivolumab plus ipilimumab combination therapy for recurrent vaginal malignant melanoma: A case report
Yano, Mitsutake
Tonai, Nobutomo
Kai, Kentaro
Nasu, Kaei
Kawano, Yasushi
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 148 : 8 - 8
[10] Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report
Ong, Claire
Samlowski, Wolfram
FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →